期刊文献+

重视良性甲状腺结节的合理应对 被引量:18

Optimal management of benign thyroid nodules
原文传递
导出
摘要 甲状腺结节已成为常见病,大部分结节经过超声影像和甲状腺细针穿刺活检(FNAB)鉴定可陂确认为良性病变。考虑到超声引导下的FNAB细胞学结果假阴性率低,及随访中基于超声模型能发现更多遗漏的甲状腺癌,细胞学良性结节应进行超声随访。一旦出现结节生长或新的恶性征象,可考虑再次实施FNAB。良性结节的治疗方法主要包括药物、经皮无水酒精注射、热消融和手术。应充分权衡良性甲状腺结节治疗的获益和风险,避免过度治疗。 Thyroid nodules are a common clinical problem, the majority of which are regarded as benign nodules by initial fine-needle aspiration biopsy ( FNAB ) or ultrasound characteristics. Given the low false negative rate of ultrasound-guided FNAB cytology and the higher yield of missed malignancies based upon nodule sonographic pattern, a routine sonographic surveillance is recommended to the thyroid nodules with benign cytology. If there are any sonographic evidence of growth or development of new suspicious sonographic features, the FNAB could be repeated. Treatment for benign thyroid nodules includes medications, percutaneous ethanol injection, thermal ablation and surgery. In order to avoid over-treatment, the potential harm and benefits of any intervention should be assessed.
作者 徐书杭 刘超
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2016年第8期707-710,共4页 Chinese Journal of Endocrinology and Metabolism
关键词 甲状腺结节 良性 管理 随访 Thyroid nodules Benign Management Follow-up
  • 相关文献

参考文献15

  • 1WangK,YangY,WuY,et al.The association between insulin resistance and vascularization of thyroid nodules.J Clin Endocrinol Metab,2015,100(1):184-192.
  • 2冯尚勇,朱妍,张真稳,段宇,刘晓云,王晓东,唐伟,茅晓东,徐书杭,冯雨,刘翠萍,覃又文,沈洪兵,喻荣彬,卜瑞芳,陈军建,李伟,史泽民,胡旭,刘超.江苏社区人群甲状腺结节的流行病学研究[J].中华内分泌代谢杂志,2011,27(6):492-494. 被引量:67
  • 3XuW,ChenZ,LiuH,et al.The association of thyroid nodule with non-iodized salt among Chinese children[J].PLoS One,2014,9(7):e102726.
  • 4中华医学会内分泌学分会,中华医学会外科学分会内分泌学组,中国抗癌协会头颈肿瘤专业委员会,等.甲状腺结节和分化型甲状腺癌诊治指南.中华内分泌代谢杂志,2012,28:779-797.
  • 5WeiX,LiY,ZhangS,et al.Thyroid imaging reporting and data system(TI-RADS)in the diagnostic value of thyroid nodules:a systematic review[J].Tumour Biol,2014,35(7):6769-6776.
  • 6ZhangJ,LiuBJ,XuHX,et al.Prospective validation of an ultrasound-based thyroid imaging reporting and data system(TI-RADS)on 3980 thyroid nodules[J].Int J Clin Exp Med,2015,8(4):5911-5917.
  • 7American Thyroid Association(ATA)Guidelines Taskforce on thyroid nodules and differentiated thyroid cancer,CooperDS,DohertyGM,et al.Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.Thyroid,2009,19(11):1167-1214.
  • 8LeeMJ,KimEK,KwakJY,et al.Partially cystic thyroid nodules on ultrasound:probability of malignancy and sonographic differentiation.Thyroid,2009,19(4):341-346.
  • 9ItoY,MiyauchiA,KiharaM,et al.Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation.Thyroid,2014,24(1):27-34.
  • 10KimSY,HanKH,MoonHJ,et al.Thyroid nodules with benign findings at cytologic examination:results of long-term follow-up with US[J].Radiology,2014,271(1):272-281.

二级参考文献27

  • 1武晓泓,陆晓婕,刘超,狄福松,何戎华,蒋须勤.甲状腺偶发结节的筛查及随访[J].中国实用内科杂志,2005,25(9):823-824. 被引量:30
  • 2Guo H,Sun M,He W,et al.The prevalence of thyroid nodules and its relationship with metabolic parameters in a Chinese community-based population aged over 40 years.Endocrine,2013,[Epub ahead of print].
  • 3Siegel R,Naishadham D,Jemal A.Cancer statistics,2013.CA Cancer J Clin,2013,63:11-30.
  • 4Bifulco M.Therapeutic potential of statins in thyroid proliferative disease.Nat Clin Pract Endocrinol Metab,2008,4:242-243.
  • 5Zeybek ND,Gulcelik NE,Kaymaz FF,et al.Rosuvastatin induces apoptosis in cultured human papillary thyroid cancer cells.J Endocrinol,2011,210:105-115.
  • 6Zhong WB,Hsu SP,Ho PY,et al.Lovastatin inhibits proliferation of anaplastic thyroid cancer cells through up-regulation of p27 by interfering with the Rho/ROCK-mediated pathway.Biochem Pharmacol,2011,82:1663-1672.
  • 7Shui HA,Hsia CW,Chen HM,et al.Proteomics and bioinformatics analysis of lovastatin-induced differentiation in ARO cells.J Proteomics,2012,75:1170-1180.
  • 8Chung YS,Cho S,Ryou HJ,et al.Is there a treatment advantage when paclitaxel and lovastatin are combined to dose anaplastic thyroid carcinoma cell lines.Thyroid,2011,21:735-744.
  • 9Wang CY,Shui HA,Chang TC.In vivo evidence of duality effects for lovastatin in a nude mouse cancer model.Int J Cancer,2010,126:578-582.
  • 10Fang Z,Tang Y,Fang J,et al.Simvastatin inhibits renal cancer cell growth and metastasis via AKT/mTOR,ERK and JAK2/STAT3 pathway.PLoS One,2013,8:e62823.

共引文献81

同被引文献142

引证文献18

二级引证文献125

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部